SLF
PVLA

Sun Life Financial’s Palvella Therapeutics PVLA Stock Holding History

Sun Life Financial’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-120
Closed -$33K – 589
2019
Q3 		$33K Hold
120
– – 0.01% 343
2019
Q2 		$45K Hold
120
– – 0.01% 299
2019
Q1 		$32K Buy
120
+1
+0.8% +$238 0.01% 417
2018
Q4 		$25K Buy
119
+1
+0.8% +$310 0.01% 535
2018
Q3 		$53K Buy
+118
New +$51.3K 0.01% 432

Other funds holding PVLA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sun Life Financial's PVLA Position: Q4 2019 in Review

Sun Life Financial sold out of Palvella Therapeutics (PVLA) in Q4 2019, closing a stake of 120 shares — an estimated $33K sold.

Sun Life Financial first reported a position in PVLA in Q3 2018 and held it in 5 quarters. The position peaked at $53K in Q3 2018. 97 funds tracked by Wall St. Rank hold PVLA as of Q4 2019.

  • Sun Life Financial reported no remaining Palvella Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Sun Life Financial sold 120 Palvella Therapeutics shares in Q4 2019, an estimated $33K.
  • Sun Life Financial first reported a position in Palvella Therapeutics in Q3 2018 and held it in 5 quarters.
  • Sun Life Financial's Palvella Therapeutics position peaked at $53K in Q3 2018.
  • 97 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q4 2019.

Based on Sun Life Financial's 13F filing for Q4 2019, filed 10 Feb 2020.